Financhill
Back

Hypera SA 10K Form

Sell
22

HYPMY
Hypera SA

Last Price:
3.59
Seasonality Move:
4.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HYPMY News And Ratings

See the #1 stock for the next 7 days that we like better than HYPMY

HYPMY Financial Statistics

Sales & Book Value

Annual Sales: $1.59B
Cash Flow: $85.79M
Price / Cash Flow: 6.2
Annual Sales: $3.45
Price / Book: 1.05

Profitability

EPS (TTM): 0.52990
Net Income (TTM): $338.01M
Gross Margin: $1B
Return on Equity: 14.78%
Return on Assets: 6.92%

Hypera SA Earnings Forecast

Key Hypera SA Financial Ratios

  • The Gross Profit Margin over the past 19 years for HYPMY is 63.12%.
  • The Selling, General & Administrative Expenses for HYPMY have been equal to 22.44% of Gross Profit Margin.
  • The Research & Development expenses have been 2.14% of Revenue.
  • The Interest Expense is 68.52% of Operating Income.
  • The Net Earning history of HYPMY is 20.82% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 9 years.

Hypera SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: HYPMY
Website: hypermarcas.com.br

Debt

Debt-to-Equity Ratio: 0.85
Current Ratio: 1.89
Quick Ratio: 1.39

Price-to-Earnings

Trailing P/E Ratio: 7.03
Forward P/E Ratio: 0

HYPMY Technical Analysis vs Fundamental Analysis

Sell
22
Hypera SA (HYPMY) is a Sell

Is Hypera SA a Buy or a Sell?

  • Hypera SA stock is rated a Sell
    The current Hypera SA [HYPMY] share price is $3.64. The Score for HYPMY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.